Endocrine Abstracts (2002) 3 P106

Audit on lipid management in diabetes

PK Moulik, C Nethaji, B Arsalanizadeh & AA Khaleeli


Halton General Hospital, Runcorn, UK.


Background and aims: Cardiovascular (CVS) disease accounts for the majority of morbidity and mortality in diabetes. We audited lipid management in a hospital diabetes clinic.

Patients: CVS disease risk factors were assessed in 241 consecutive patients with diabetes (type1 15%, type2 85%, male 53%, female 47%, mean age 59±13 years, mean duration of diabetes 10±9 years). 86(36%) had symptomatic atherosclerotic vascular disease (secondary prevention SP) and 155 (64%) did not (primary prevention PP).

Results: Overall, 37% were on statins, 7.5% on fibrates and 1% on acipimox. Combination hypolipidemic therapy was prescribed to 5 patients. In SP, mean total cholesterol (TC), HDL, LDL and triglycerides were 5.0, 1.3, 2.8 and 2.0 mmol/l respectively. Corresponding values for PP was 5.3, 1.4, 3.0 and 2.0 mmol/l. Mean TC in SP was significantly lower than PP (p=0.04), likely due to more intensive intervention and better compliance. Mean LDL and triglycerides were similar, though HDL was lower in SP (p=0.03). Target TC (less than 5.0 mmol/l) was achieved in 49% SP, 22% PP with 10-year coronary heart disease (CHD) risk greater than 30% and 38% PP with 10-year CHD risk 15%-30%. In PP, median 10-year CHD risk was 15%. Only 9 (6%) of these patients had 10-year CHD risk greater than 30%, none were on hypolipidemic therapy. Three patients were above 80 years age and 2 had TC less than 5.0 mmol/l.

Conclusion: Targeted therapy of PP patients with 10-year CHD risk greater than 15% is recommended. Strategies to increase HDL and further intensified therapy, if necessary with combinations of hypolipidemic agents, is recommended in SP.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts